Novo weight loss drug trial shows improvement in fatty liver disease
Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of the organ without worsening the condition.
BELIEBTE BEITRÄGE
Vigilante groups patrol flood zone in Paiporta
November 7, 2024
At least 89 people are missing in flooding in eastern Spain
November 7, 2024
Hurricane Rafael hit the Cayman Islands
November 7, 2024
‘The Office’ Christmas storybook is number one bestseller on Amazon
November 7, 2024
LIVEÜBERTRAGUNG